Below is an example of 1 of Mesoblast's many hundreds of granted patents that seeks to protect its IP around MSC'S and cell therapy.
To fund every single trial for every application is impossible. Treating the most severe form of inflammation and reversing this process resulting in survival as opposed to death goes a ling way to supporting alternative apllications.
Unmet needs is just the start for cell therapy. Once the foot is in the door the ball game will change IMO.
Paradigm Shift
Joint repair using mesenchymal stem cells
Patent number: 9814580
Abstract: A method of repairing and/or stabilizing a joint by administering mesenchymal stem cells to the joint. Such a method provides for the regeneration of cartilaginous tissue in the joint, including meniscal tissue.
Type: Grant
Filed: April 16, 2015
Date of Patent: November 14, 2017
Assignee: MESOBLAST INTERNATIONAL SARL
Inventors: Francis P. Barry, J. Mary Murphy, Robert Deans, David J. Fink, Annemarie Moseley
Market opportunity aGVHD, page-41
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |